0 CHECKOUT

PRODUCT FILTERS

REGION

3
2
2
2

COUNTRY

2

CATEGORIES

  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

0
1
4
6

PUBLISHED

0
1
2
6

PRODUCT TYPE

4
2

Search for: "EPIX Pharmaceuticals, Inc.-Detailed Product Pipeline"

Neurotech Industry 2015-2016 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System

Now in its 11th year, The Neurotechnology Industry 2015-2016 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide...

Published:  September 2015
Price:  From

MicroDose Therapeutx, Inc. - Product Pipeline Review - 2012

MicroDose Therapeutx, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “MicroDose Therapeutx, Inc. - Product Pipeline Review - 2012” provides data on the...

Published:  November 2012
Price:  From

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

The Global Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

Published:  February 2016
Price:  From

Schizophrenia Therapeutics Market in the US: Market Forecast, Patient Flow, and Competitive Landscape

The global schizophrenia therapeutics market was valued at $6 7 billion in 2010, and is expected to reach $7 3 billion by 2018, increasing at a CAGR of 7 5% between 2010 and 2018 The US schizophrenia...

Published:  May 2011
Price:  From

Forest Laboratories, Inc. - Product Pipeline Review - 2012

Forest Laboratories, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Forest Laboratories, Inc. - Product Pipeline Review - 2012” provides data on the...

Published:  November 2012
Price:  From

Global Schizophrenia Therapeutics Market: Market Forecast, Patient Flow, Competitive Landscape, and Pipeline Analysis

The global schizophrenia therapeutics market was valued at $6 7 billion in 2010, and is expected to reach $7 3 billion by 2018, increasing at a CAGR of 7 5% between 2010 and 2018 Schizophrenia markets...

Published:  May 2011
Price:  From
Loading Indicator

Our Clients

  • Goodyear Tire & Rubber Company
  • GlaxoSmithKline PLC
  • Hilton Worldwide
  • Hewlett-Packard Company
  • Accenture PLC.
  • Qualcomm Incorporated
  • UBS AG